Fx2016-40
ClinicalTrials.gov NCT04104685
Research payments
$1,489,934
Through program year 2020, $1,489,934 in research payments was reported against Fx2016-40, across 263 payments, paid by VYNE Pharmaceuticals Inc..
- Paid by
- VYNE Pharmaceuticals Inc.
- ClinicalTrials.gov
- NCT04104685
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $1,489,934 | 263 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lilia Rodriguez Ables Miami, FL Named on 19 payments
- Deirdre Hooper New Orleans, LA Named on 16 payments
- Ira Thorla Baton Rouge, LA Named on 16 payments
- Neal Bhatia San Diego, CA Named on 15 payments
- Bun Siu Huntington Beach, CA Named on 14 payments
- Frank Calcagno Gresham, OR Named on 12 payments
- Scott Checketts Layton, UT Named on 11 payments
- Angela Moore Arlington, TX Named on 10 payments
- Lesley CLARK-LOESER Davie, FL Named on 10 payments
- Ellen Frankel Cranston, RI Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.